NCT04444622
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04444622
Title Immunotherapy for Third Line Metastatic Colorectal Cancer (STIMVAX)
Acronym STIMVAX
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirror Biologics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mt. Sinai Comprehensive Cancer Center Miami Beach Florida 33140 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Summit Health Florham Park New Jersey 07932 United States Details
Hirschfield Oncology Center The Bronx New York 10469 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field